FindTrial
Sign In

histrelin acetate

DRUG3 trials

Sponsors

Endo Pharmaceuticals, University of Colorado, Denver, SWOG Cancer Research Network

Conditions

Adenocarcinoma of the ProstateCastration Levels of TestosteroneMetastatic Prostatic AdenocarcinomaProstate CancerRecurrent Prostate CancerStage III Prostate CancerStage IV Prostate CancerStage IV Prostate Cancer AJCC v8

Phase 2

Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer
CompletedNCT02278185
University of Colorado, DenverAdenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage III Prostate Cancer +1
Start: 2015-11-11End: 2024-07-18Updated: 2025-05-11

Phase 3

Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer
CompletedNCT01697384
Endo PharmaceuticalsAdenocarcinoma of the Prostate, Prostate Cancer
Start: 2000-04-30End: 2004-10-31Updated: 2024-01-02
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecruitingNCT03678025
SWOG Cancer Research NetworkCastration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IVA Prostate Cancer AJCC v8 +2
Start: 2018-09-24End: 2031-10-01Target: 1273Updated: 2025-09-11

Related Papers

Safety and Efficacy Study of Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer: Protocol of an Open-Label, Dose-Escalation, Single-Centre Phase I/II Clinical Trial
Cancer Control2022-08-18
Metastatic prostate cancer men’s attitudes towards treatment of the local tumour and metastasis evaluative research (IP5-MATTER): protocol for a prospective, multicentre discrete choice experiment study
BMJ Open2021-11-013 citations